Literature DB >> 22889614

The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry.

Hans Henrik Gad1, Sylvie Paulous, Essia Belarbi, Laure Diancourt, Christian Drosten, Beate M Kümmerer, Aileen E Plate, Valérie Caro, Philippe Desprès.   

Abstract

Human 2',5'-oligoadenylate synthetase 3 (OAS3) exerts antiviral effect against alphaviruses including Chikungunya virus (CHIKV) by inhibiting viral RNA accumulation. Here, we identified a CHIKV variant exhibiting a remarkable resistance to the antiviral action of OAS3 in human epithelial HeLa cells. Using a molecular clone of CHIKV with Renilla luciferase inserted as a reporter gene in the non-structural region, we demonstrated that a single glutamine-to-lysine amino acid change at position 166 of the envelope E2 glycoprotein restores CHIKV replication in OAS3 expressing HeLa cells. Viral entry assays showed that CHIKV with a lysine at position E2-166 was more efficient at entering the replicative pathway. The E2-E166K substitution promotes a greater efficiency of CHIKV replication in human myoblasts leading to severe apoptosis through a more robust activation of the PKR pathway. These observations provide a new insight into the role of E2 into the pathogenicity of CHIKV in human cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889614     DOI: 10.1016/j.virol.2012.07.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.

Authors:  Junnan Zhang; Jie Shao; Xing Wu; Qunying Mao; Yiping Wang; Fan Gao; Wei Kong; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The growth of arthralgic Ross River virus is restricted in human monocytic cells.

Authors:  Pascale Krejbich-Trotot; Essia Belarbi; Miora Ralambondrainy; Chaker El-Kalamouni; Wildriss Viranaicken; Pierre Roques; Philippe Desprès; Gilles Gadea
Journal:  Virus Res       Date:  2016-09-13       Impact factor: 3.303

3.  Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model.

Authors:  J J Ruotsalainen; M U Kaikkonen; M Niittykoski; M W Martikainen; C G Lemay; J Cox; N S De Silva; A Kus; T J Falls; J-S Diallo; F Le Boeuf; J C Bell; S Ylä-Herttuala; A E Hinkkanen; M J Vähä-Koskela
Journal:  Gene Ther       Date:  2014-09-18       Impact factor: 5.250

4.  Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Anandkumar Tengli
Journal:  Gene Rep       Date:  2020-11-04

5.  High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses.

Authors:  Marianne Lucas-Hourani; Hélène Munier-Lehmann; Olivier Helynck; Anastassia Komarova; Philippe Desprès; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  J Vis Exp       Date:  2014-05-05       Impact factor: 1.355

Review 6.  Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases.

Authors:  Un Yung Choi; Ji-Seon Kang; Yune Sahng Hwang; Young-Joon Kim
Journal:  Exp Mol Med       Date:  2015-03-06       Impact factor: 8.718

7.  Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway.

Authors:  Pierre-Emmanuel Joubert; Kenneth Stapleford; Florence Guivel-Benhassine; Marco Vignuzzi; Olivier Schwartz; Matthew L Albert
Journal:  PLoS Pathog       Date:  2015-08-28       Impact factor: 6.823

Review 8.  Antiviral perspectives for chikungunya virus.

Authors:  Deepti Parashar; Sarah Cherian
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

9.  Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity.

Authors:  Marianne Lucas-Hourani; Daniel Dauzonne; Pierre Jorda; Gaëlle Cousin; Alexandru Lupan; Olivier Helynck; Grégory Caignard; Geneviève Janvier; Gwénaëlle André-Leroux; Samira Khiar; Nicolas Escriou; Philippe Desprès; Yves Jacob; Hélène Munier-Lehmann; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

10.  Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.

Authors:  Christina L Gardner; Jozef Hritz; Chengqun Sun; Dana L Vanlandingham; Timothy Y Song; Elodie Ghedin; Stephen Higgs; William B Klimstra; Kate D Ryman
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.